These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1810062)

  • 1. [The clinical manifestations and the plasma levels of fibronectin and fibrin-fibrinogen degradation products in different morphological forms of chronic hepatitis].
    Malaia LT; Iabluchanskiĭ NI; Panchuk SN; Babak OIa
    Ter Arkh; 1991; 63(11):44-6. PubMed ID: 1810062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular degradation forms of plasma fibronectin in patients with chronic obstructive pulmonary disease].
    Ding YH; Lu YQ; Cheng JG
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):305-7, 320. PubMed ID: 7712576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of forms of chronic hepatitis].
    Markiewicz K; Bubiński R
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):76-82. PubMed ID: 4006842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibronectin in acute and chronic hepatitis].
    Malaia LT; Babak OIa; Iabluchanskiĭ NI; Sharov EI
    Klin Med (Mosk); 1990 Nov; 68(11):37-9. PubMed ID: 2283810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of plasma fibronectin on the response to infusion of thrombin and adenosine diphosphate.
    Kaplan JE; Snedeker PW; Baum SH; Moon DG; Minnear FL
    Thromb Haemost; 1983 Jun; 49(3):217-23. PubMed ID: 6879510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of aminotransferases to liver histological status in chronic hepatitis C.
    Haber MM; West AB; Haber AD; Reuben A
    Am J Gastroenterol; 1995 Aug; 90(8):1250-7. PubMed ID: 7639225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibronectin and serum complement C3 levels in chronic active hepatitis following virus "B" versus virus "C" infection.
    Abdel Rahman MM; el Nasr MS; Mahmoud SA; Soliman A; Salama MM
    J Egypt Soc Parasitol; 1993 Aug; 23(2):579-89. PubMed ID: 8376876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis: indicators of disease activity].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2000; 72(2):17-8. PubMed ID: 10717917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the fibrin fibrinogen degradation products levels and it's significance in the phlegm of the patients with chronic cor pulmonale through monoclonal antibodies].
    He GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):154-6, 191. PubMed ID: 2249318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating complexes of plasma fibronectin (fibronectin-fibrin) in human diseases].
    Vasil'ev SA; Efremov EE; Savenko TA; Ermolin GA; Ignashenkova GV; Zherdeva LV
    Ter Arkh; 1994; 66(2):63-6. PubMed ID: 8160151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between immunohistochemical markers and morphological picture in chronic hepatitis].
    Oddi G; Rebeck L; Caci R; De Lisi M
    Minerva Med; 1991 Jun; 82(6):363-6. PubMed ID: 2067708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic active hepatitis: the clinical, biochemical and histopathological correlations].
    Subauste MC
    Rev Gastroenterol Peru; 1989; 9(1):29-40. PubMed ID: 2490974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of fibrinogen-fibrin degradation factors in neoplasms].
    Petrella V; Massara G; Parachini F; Silvera F; Cantone R
    Minerva Med; 1988 Feb; 79(2):117-21. PubMed ID: 3352945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma fibronectin in chronic liver diseases].
    Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
    Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, biochemical, and morphological characteristics of chronic hepatitis with various etiology].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2002; 74(2):35-7. PubMed ID: 11899821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.